Global Glaucoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- SKU ID : GIR-GIR1903180055 14348890
- |
- Publishing Date: 19-Aug-2019
- |
- Region: Global
- |
- No. of pages: 118
Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible.
Scope of the Report:
In the last several years, Hong Kong market of Glaucoma Treatment developed rapidly, with an average growth rate of 4% during 2013 to 2018. In 2018, Hong Kong revenue of Glaucoma Treatment is nearly 73 M USD.
The classification of Glaucoma Treatment includes Prostaglandin Analogs (PGAs), Beta Blocker, Alpha Agonist and other, and the proportion of Prostaglandin Analogs (PGAs) in 2018 is about 52%, and the proportion is in increasing trend from 2013 to 2018.
Glaucoma Treatment is widely used in Clinic, Pharmacy and other field. The most proportion of Glaucoma Treatment is in hospitals, and the proportion in 2018 is 66%.
The global Glaucoma Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glaucoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Glaucoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glaucoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Market Segment by Applications, can be divided into
Clinic
Pharmacy
Other
Scope of the Report:
In the last several years, Hong Kong market of Glaucoma Treatment developed rapidly, with an average growth rate of 4% during 2013 to 2018. In 2018, Hong Kong revenue of Glaucoma Treatment is nearly 73 M USD.
The classification of Glaucoma Treatment includes Prostaglandin Analogs (PGAs), Beta Blocker, Alpha Agonist and other, and the proportion of Prostaglandin Analogs (PGAs) in 2018 is about 52%, and the proportion is in increasing trend from 2013 to 2018.
Glaucoma Treatment is widely used in Clinic, Pharmacy and other field. The most proportion of Glaucoma Treatment is in hospitals, and the proportion in 2018 is 66%.
The global Glaucoma Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glaucoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Glaucoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glaucoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Market Segment by Applications, can be divided into
Clinic
Pharmacy
Other
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
